VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Metformin use and respiratory outcomes in asthma-COPD overlap.
Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
HO, DAVID
One or more keywords matched the following items that are connected to
HO, DAVID
Item Type
Name
Academic Article
Determining the relative efficacy of highly active antiretroviral therapy.
Academic Article
A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo.
Academic Article
Estimates of intracellular delay and average drug efficacy from viral load data of HIV-infected individuals under antiretroviral therapy.
Concept
Cysteine Proteinase Inhibitors
Concept
Protease Inhibitors
Concept
HIV Protease Inhibitors
Concept
Proteasome Endopeptidase Complex
Academic Article
CRISPR-based gene knockout screens reveal deubiquitinases involved in HIV-1 latency in two Jurkat cell models.
Academic Article
A simplified cell-based assay to identify coronavirus 3CL protease inhibitors.
Academic Article
Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors.
Academic Article
Functional map of SARS-CoV-2 3CL protease reveals tolerant and immutable sites.
Academic Article
Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19.
Academic Article
Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors.
Academic Article
The Functional Landscape of SARS-CoV-2 3CL Protease.
Academic Article
Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors.
Academic Article
Inhibitors of Coronavirus 3CL Proteases Protect Cells from Protease-Mediated Cytotoxicity.
Academic Article
Persistence of an infectious form of SARS-CoV-2 post protease inhibitor treatment of permissive cells in vitro.
Search Criteria
Endopeptidase K